In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Helicobacter pylori infection
Simplified dual therapy beats quadruple regimen
- Gastric carcinoma
Ways of precision oncology
- Endometrial Cancer
Immunological drivers and new therapeutic pathways
- Exercise for type 1 diabetes
Cyclists and runners with an increased risk of hypoglycemia
- Ozanimod for relapsing-remitting multiple sclerosis
Signs of improved tolerability with prolonged treatment
- When basal cell carcinomas prove difficult to treat
Reaching the goal with innovative therapy strategies
- Irritable Bowel Syndrome
IBS or endometriosis?
- Type 2 diabetes: sarcopenia and frailty